List of Figures
Figure 1: Pain Therapeutics Market, Global, Epidemiology Patterns for Migraine, 2016–2023 15
Figure 2: Pain Therapeutics Market, Global, Epidemiology Patterns for Post-Herpetic Neuralgia, 2016–2023 16
Figure 3: Pain Therapeutics Market, Global, Annual Revenue for Nucynta ($m), 2015–2023 25
Figure 4: Pain Therapeutics Market, Global, Annual Revenue for Lyrica ($bn), 2006–2023 27
Figure 5: Pain Therapeutics Market, Global, Annual Revenue for Voltaren ($m), 2006–2023 29
Figure 6: Pain Therapeutics Market, Global, Annual Revenue for Pennsaid ($m), 2015–2023 30
Figure 7: Pain Therapeutics Market, Global, Annual Revenue for Depakine ($m), 2006–2023 31
Figure 8: Pain Therapeutics Market, Global, Annual Revenue for Embeda ER ($m), 2016–2023 32
Figure 9: Pain Therapeutics Market, Global, Annual Revenue for Cymbalta ($bn), 2006–2023 33
Figure 10: Pain Therapeutics Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2017 35
Figure 11: Pain Therapeutics Market, Global, Pipeline by Stage of Development, Molecule Type and Program Type, 2017 36
Figure 12: Pain Therapeutics Market, Global, Pipeline, Key Indications by Stage of Development, 2017 37
Figure 13: Pain Therapeutics Market, Global, Pipeline, Key Indications by Molecule Type, 2017 38
Figure 14: Pain Therapeutics Market, Global, Overall Pipeline by Molecular Target, 2017 40
Figure 15: Pain Therapeutics Market, Global, Pipeline by Neurotransmission Molecular Target, 2017 41
Figure 16: Pain Therapeutics Market, Global, Pipeline for Key Indications by Molecular Target, 2017 42
Figure 17: Pain Therapeutics Market, Global, Clinical Trial Failure Rates by Stage of Development and Indication (%), 2006–2017 44
Figure 18: Pain Therapeutics Market, Global, Clinical Trial Failure Rates by Stage of Development and Molecular Target (%), 2006–2017 45
Figure 19: Pain Therapeutics Market, Global, Clinical Trial Duration by Stage of Development (months), 2006–2017 46
Figure 20: Pain Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Indication (months), 2006–2017 47
Figure 21: Pain Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2006–2017 48
Figure 22: Pain Therapeutics Market, Global, Clinical Trial Size by Stage of Development (participants), 2006–2017 48
Figure 23: Pain Drug Market, Global, Clinical Trial Size by Stage of Development and Indication (participants), 2006–2017 49
Figure 24: Pain Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecular Target (participants), 2006–2017 50
Figure 25: Pain Therapeutics Market, Global, Aggregate Clinical Program Size by Stage of Development (participants), 2006–2017 51
Figure 26: Pain Therapeutics Market, Global, Aggregate Clinical Program Size by Stage of Development and Indication (participants), 2006–2017 52
Figure 27: Pain Therapeutics Market, Global, Aggregate Clinical Program Size by Stage of Development and Molecular Target (participants), 2006–2017 53
Figure 28: Pain Therapeutics Market, Global, Revenue Forecast for HTX-011 ($m), 2019–2023. 55
Figure 29: Pain Therapeutics Market, Global, Revenue Forecast for Difelikefalin ($m), 2018–2023. 56
Figure 30: Pain Therapeutics Market, Global, Revenue Forecast for Fremanezumab ($m), 2018–2023 57
Figure 31: Pain Therapeutics Market, Global, Revenue Forecast for Eptinezumab ($m), 2018–2023 58
Figure 32: Pain Therapeutics Market, Global, Revenue Forecast for Erenumab ($m), 2018–2023 59
Figure 33: Pain Therapeutics Market, Global, Revenue Forecast for Galcanezumab ($m), 2018–2023 60
Figure 34: Pain Therapeutics Market, Global, Revenue Forecast for Zilretta ($m), 2017–2023 61
Figure 35: Pain Therapeutics Market, Global, Revenue Forecast for EMA-401 ($m), 2019–2023 62
Figure 36: Pain Therapeutics Market, Global, Market Size ($bn), 2016–2023 64
Figure 37: Pain Therapeutics Market, Global, Annual Revenue by Premium and Generic Products ($bn), 2016–2023 67
Figure 38: Pain Therapeutics Market, Global, Annual Revenue for Generic Fentanyl ($bn), 2016–2023 69
Figure 39: Pain Therapeutics Market, Global, Annual Revenue for Generic Hydromorphone ($m), 2016–2023 70
Figure 40: Pain Therapeutics Market, Global, Annual Revenue for Generic Methadone ($m), 2016–2023 71
Figure 41: Pain Therapeutics Market, Global, Annual Revenue for Generic Morphine ($bn), 2016–2023 72
Figure 42: Pain Therapeutics Market, Global, Annual Revenue for Generic Oxycodone ($bn), 2016–2023 73
Figure 43: Pain Therapeutics Market, Global, Annual Revenue Forecast for Drugs Acting on Opioid Receptors ($bn), 2016–2023 74
Figure 44: Pain Therapeutics Market, Global, Annual Revenue Forecast for Drugs Acting on Serotonin Receptors 1B and 1D ($m), 2016–2023 75
Figure 45: Pain Therapeutics Market, Global, Annual Revenue Forecast for Drug Acting on Prostaglandin Signaling ($bn), 2016–2023 76
Figure 46: Pain Therapeutics Market, Global, Annual Revenue Forecast for Drugs Acting on CGRPR ($bn), 2016–2023 77
Figure 47: Pain Therapeutics Market, Global, Annual Revenue Forecast for Drugs Acting on Multiple Molecular Targets ($bn), 2016–2023 78
Figure 48: Pain Therapeutics Market, Global, Annual Revenue Forecast for Drugs Acting on Ion Channels ($bn), 2016–2023 79
Figure 49: Pain Therapeutics Market, Global, Cluster by Growth and Market Share, 2016–2023 80
Figure 50: Pain Therapeutics Market, Global, Company Analysis Matrix, 2017 81
Figure 51: Pain Therapeutics Market, Global, Forecast Market Share by Company (%), 2016–2023 84
Figure 52: Pain Therapeutics Market, Global, Companies by Compound Annual Growth Rate (%), 2016–2023 85
Figure 53: Pain Therapeutics Market, Global, Teva Annual Revenue Forecast, 2018–2023 86
Figure 54: Pain Therapeutics Market, Global, Pfizer Annual Revenue Forecast, 2016–2023 87
Figure 55: Pain Therapeutics Market, Global, Pacira Annual Revenue Forecast, 2016–2023 88
Figure 56: Pain Therapeutics Market, Global, Novartis Annual Revenue Forecast, 2016–2023 89
Figure 57: Pain Therapeutics Market, Global, Amgen Annual Revenue Forecast, 2018–2023 90
Figure 58: Pain Therapeutics Market, Global, Allergan Annual Revenue Forecast, 2016–2023 91
Figure 59: Pain Therapeutics Market, Global, Depomed Annual Revenue Forecast, 2016–2023 92
Figure 60: Pain Therapeutics Market, Global, Lilly Annual Revenue Forecast, 2016–2023 93
Figure 61: Pain Therapeutics Market, Global, High-Activity and Late-Stage Pipeline Developers by Type, 2017 94
Figure 62: Pain Therapeutics Market, Global, Pipeline, Overall, High-Activity and Late-Stage Developers by Level of Specialization, 2017 95
Figure 63: Pain Therapeutics Market, Global, Proportion of Total Company Revenue Attributed to Pain Therapeutics, 2016–2023 96
Figure 64: Pain Therapeutics Market, Global, Licensing Deals by Region, Value and Year, 2006–2016 98
Figure 65: Pain Therapeutics Market, Global, Licensing Deals by Indication, 2006–2017 99
Figure 66: Pain Therapeutics Market, Global, Licensing Deals by Stage of Development and Value, 2006–2016 100
Figure 67: Pain Therapeutics Market, Global, Licensing Deals by Molecule Type, Molecular Target and Aggregate Deal Value, 2006–2017 101
Figure 68: Pain Therapeutics Market, Global, Licensing Deals With Disclosed Values, 2006–2017 102
Figure 69: Pain Therapeutics Market, Global, Co-development Deals by Region, Value and Year, 2006–2017 103
Figure 70: Pain Therapeutics Market, Global, Co-development Deals by Indication and Value, 2006–2017 104
Figure 71: Pain Therapeutics Market, Global, Co-development Deals by Stage of Development, 2006–2017 105
Figure 72: Pain Therapeutics Market, Global, Co-development Deals by Molecule Type, Mechanism of Action and Aggregate Deal Value, 2006–2016 105
Figure 73: Pain Therapeutics Market, Global, Co-development Deals with Disclosed Values, 2006–2017 106